Pharmacokinetic implications associated to the use of drugs as racemates or pure enantiomers Implicancias farmacocinéticas asociadas al uso de fármacos como racematos o enantiómeros puros.
Author
dc.contributor.author
Speisky Cosoy, Hernán
Author
dc.contributor.author
Squella Serrano, Juan
Author
dc.contributor.author
Núñez Vergara, Luis
Admission date
dc.date.accessioned
2019-01-29T14:55:29Z
Available date
dc.date.available
2019-01-29T14:55:29Z
Publication date
dc.date.issued
1995
Cita de ítem
dc.identifier.citation
Revista médica de Chile, Volumen 123, Issue 7, 2018, Pages 884-891
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161387
Abstract
dc.description.abstract
This article critically reviews the recent specialized literature concerning the influence of the stereochemical nature of quiral drugs on the pharmacokinetic processes and its pharmacological implications. Evidence is presented indicating that as a function of the type of enantiomer administered, profound differences in the pharmacokinetic profiles, e.g. absorption, distribution, biotransformation and elimination can occur. As a consequence of the enantioselective nature of the drug-organism interaction, major differences in the therapeutic responses can be envisaged depending on whether the drug is administered as a pure enantiomer or as a racemic mixture.
Pharmacokinetic implications associated to the use of drugs as racemates or pure enantiomers Implicancias farmacocinéticas asociadas al uso de fármacos como racematos o enantiómeros puros.